---
title: "Telix Pharmaceuticals reports Q2 results; updates FY2026 outlook"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293286576.md"
description: "Telix Pharmaceuticals reports Q2 results; updates FY2026 outlook"
datetime: "2026-07-21T04:30:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293286576.md)
  - [en](https://longbridge.com/en/news/293286576.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293286576.md)
generator: "portal-rs"
---

# Telix Pharmaceuticals reports Q2 results; updates FY2026 outlook


### Related Stocks

- [TLX.AU](https://longbridge.com/en/quote/TLX.AU.md)
- [TLX.US](https://longbridge.com/en/quote/TLX.US.md)

## Related News & Research

- [WiseTech Global Stock And 2 Australian Shares Trading Below Cash Flow Value](https://longbridge.com/en/news/296714418.md)
- [How Investors May Respond To Telix Pharmaceuticals (ASX:TLX) Upgraded FY26 Guidance And Pipeline Milestones](https://longbridge.com/en/news/294604857.md)
- [Faron Pharmaceuticals releases H1 2026 results webcast transcript](https://longbridge.com/en/news/297049228.md)
- [Apimeds Pharmaceuticals US Enters Assignment And Transfer Agreement With Freet On August 19](https://longbridge.com/en/news/296655292.md)
- [Glenmark Pharmaceuticals Limited (NSE:GLENMARK) Looks Like A Good Stock, And It's Going Ex-Dividend Soon](https://longbridge.com/en/news/297101432.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**